Skip to main content
OpenTrials
Completed

NCT Number: NCT02909842

Effect of Drinking Fermented Milk on Immune Response

This blinded randomized controlled trial aims to investigate the effect of drinking fermented milk containing Lactobacillus paracasei (IMULUS) on immune response against influenza.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–45 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

About this study

This study is conducted in healthy volunteer using product approved by Thai FDA. This blinded randomized controlled trial compare immune response against influenza H1N1, H3N2 and Phu-B between study group and control group. The study group receives influenza vaccine and drinking fermented milk containing Lactobacillus paracasei (IMULUS), while the control group receives influenza vaccine and placebo acidified milk. The trial lasts for 8 weeks and include four time points of data collection (0, 2, 6, 8 weeks). Subjects, outcome assessor and investigators are blinded throughout the study.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18 45 years old
  • healthy and having normal vital signs
  • no history of uncontrolled systemic or autoimmune diseases
  • no signs or symptoms of respiratory infection
  • normal blood chemistry including complete blood count (CBC), liver and kidney function, lipid profile and fasting blood sugar
  • no history of influenza vaccine during the past 6 months
  • able to continuously take the intervention daily for 6 weeks
  • able to refrain from other probiotic products such as drinking fermented milk or yoghurt since the beginning till the end of data collection
  • accepted to receive influenza vaccine shot
  • able to refrain from receiving other vaccine during the trial
  • able to refrain from traveling to endemic area of influenza
  • able to communicate in Thai and sign their written inform consent

Exclusion criteria

  • under pregnancy or expected to be pregnant
  • lactose or milk protein intolerances
  • daily intake of probiotic product for one month prior to recruitment
  • chronic alcoholism
  • GI disturbance e.g. stomachache, frequent diarrhea or constipation
  • history of GI surgery
  • ongoing treatment with antibiotic or other immune affecting drugs e.g. glucocorticoids, chemotherapy, antibodies, ciclosporin, hormone and opioids

Treatment and study plan

Drinking fermented milk

Dietary Supplement

Drinking fermented milk containing Lactobacillus paracasei (IMULUS)

Placebo

Dietary Supplement

Acidified placebo milk with similar physical characteristics to the yoghurt drink

Seasonal Influenza Vaccine (H1N1, H3N2, PhuB)

Biological

Intramuscular injection of a single shot of influenza vaccine

Primary outcomes

  1. Immune response rate for H1N1, H3N2 and Phu-B virus

    Time frame: 4 weeks after vaccination

    Number of subjects with increased HAI titer from baseline divided by total number of subjects

Secondary outcomes

  1. Antibody response rate for influenza A (H1N1+H3N2) virus

    Time frame: 4 weeks after vaccination

    Number of subjects with increased Immunoglobulin G or M (IgG or IgM) antibody levels from baseline divided by total number of subjects

  2. Changes from baseline immunoglobulin M (IgM) levels for influenza A (H1N1+H3N2) virus

    Time frame: 0, 2, 6 and 8 weeks after baseline

    Changes in serum levels of IgM antibody against influenza A, detected by ELISA assay

  3. Changes from baseline immunoglobulin G (IgG) levels for influenza A (H1N1+H3N2) virus

    Time frame: 0, 2, 6 and 8 weeks after baseline

    Changes in serum levels of IgG antibody against influenza A, detected by ELISA assay

  4. Changes from baseline HAI titer for H1N1, H3N2 and Phu-B virus

    Time frame: 0, 2, 6 and 8 weeks after baseline

    Changes in maximum dilution of serum, detected by Heme agglutination inhibition (HAI) assay , which can immunologically react against H1N1, H3N2 and Phu-B virus

Sponsors and collaborators

Lead sponsor

Mahidol University

Other

Registry information

Official study title

Immunomodulating Effects of Drinking Fermented Milk Containing Lactobacillus Paracasei (IMULUSTM): a Randomized Controlled Trial Using an Influenza Vaccination Model

Important dates

Study start
2016
Primary completion
2016
Study completion
2017
First posted
Sep 21, 2016
Registry last updated
Aug 29, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.